
Execupharm (India) Private Limited
About Execupharm (India) Private Limited
Data last updated:
Execupharm (India) Private Limited was a private limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Execupharm International Llc, Usa. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the personal services segment of the professional services sector. It was incorporated on 12 February 2013.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2013PTC067830. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Bharamappa Baloj and Suma Valloli Radhakrishna.
Its last annual general meeting (AGM) was held on 05 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at S – 04 1st And 2nd Floor Ibis Hotel 26/1 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068.
As per the financials filed for FY 2017, the company reported a revenue of ₹33.41 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹4.92 Lakh (net margin 14.7%) and EBITDA of ₹9.76 Lakh (EBITDA margin 29.2%).
Company details
Contact details
Execupharm (India) Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS – 04 1st And 2nd Floor Ibis Hotel 26/1 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068
- IndustryProfessional Services, Personal, Scientific, Technical
To see the full contact details of Execupharm (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Execupharm (India) Private Limited
FY 2020 filings availableExecupharm (India) Private Limited reported revenue of ₹33.41 Lakh (down 18% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 18% in the latest year. EBITDA fell 15% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹33.41 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹9.76 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹4.92 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 29.2% | ||
| Net Profit Margin | 14.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Execupharm (India) Private Limited, buy the company report.
Board of directors of Execupharm (India) Private Limited
Execupharm (India) has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharamappa Baloj Also directs: Movik Networks India Private Limited, BRSS Prime Estates Private Limited, Zettics India Private Limited and 1 more | Director | 05 Aug 2014 | 12 Years 3 Months | As last reported |
| Suma Valloli Radhakrishna | Director | 15 Apr 2019 | 7 Years 7 Months | As last reported |
Auditor
Execupharm (India) Private Limited is audited by Chaturvedi & shah for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chaturvedi & shah | FY 2017 | 101720W |
Shareholding
The shareholding of Execupharm (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Execupharm (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Execupharm (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Execupharm (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Execupharm (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Execupharm (India) Private Limited, buy the company report.
Recent activity
Execupharm (India) Private Limited has 9 board changes on record since 2014: 2 appointments and 7 cessations. The latest: Suma Valloli Radhakrishna ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Execupharm (India) has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Execupharm (India) was a private limited company based in Bangalore, Karnataka, India. The company worked in personal, within the professional services industry. It was incorporated on 12 February 2013 and is registered under CIN U73100KA2013PTC067830. The company has been struck off by the Registrar of Companies and is no longer operational.
Execupharm (India) had 2 directors:
- Bharamappa Baloj - Director
- Suma Valloli Radhakrishna - Director
The CIN (Corporate Identification Number) of Execupharm (India) is U73100KA2013PTC067830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Execupharm (India) is at S – 04 1st And 2nd Floor Ibis Hotel 261 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068.
Execupharm (India) was incorporated on 12 February 2013. It is registered with the Registrar of Companies, Bangalore.
The latest financial statements of Execupharm (India) on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 05 December 2020. Year-wise statements from 2015 are in the company report.
No. Execupharm (India) has 1 GST registration on record and it is cancelled or inactive.
Execupharm (India) operated in the professional services industry, in the personal segment. It worked in this industry before it was struck off.
Suma Valloli Radhakrishna ceased to be Additional Director on 30 Sep 2019. Samuel Stephen Porrecca ceased to be Director on 02 Aug 2019. Suma Valloli Radhakrishna was appointed as Director on 15 Apr 2019. Execupharm (India) has 9 board changes on record in total.

